the aid library

LIST OPTIONS

Filter

4491

Arsenic Mitigation in Bangladesh

United Nations Children’s Fund (UNICEF) (2010)

Arsenic contaminated tube well water was first detected in Bangladesh in early 1990s. The arsenic comes from naturally arsenic-rich material delivered by the region's river systems, deposited over many years to make up the land of Bangladesh. Arsenic contamination is not caused by tube wells, or by ... more

Download (161)

View PDF (192)

Libya: Mixed Migration Routes and Dynamics in Libya in 2018, June 2019

IMPACT Initiatives UNHCR (2019) C1

The present report is based on a longitudinal analysis of assessments on mixed migration routes and dynamics, conducted over the course of 2018. It is based on six rapid thematic studies, conducted over the course of 2018, as well as a longitudinal analysis of changes in mixed migration routes and d... more

External Link

Amnesty International Report 2021/22: The state of the world's human rights
recommended

Amnesty International (2022) C1

mnesty International’s annual report on the state of the world’s human rights in 2021, published in March 2022, shows that promises to “build back better” after the Covid-19 pandemic were little more than lip service. Hopes of global cooperation withered in the face of vaccine hoarding and c... more

Download (190)

View PDF (223)

Evidence Brief HIV Stigma and Discrimination in the World of Work: Findings from the People Living with HIV Stigma Index

GNP (Global Network of people living HIV); ILO (International Labour Organization) (2018) C2

Evidence Brief

Download (176)

View PDF (282)

Information bulletin no. 1 Americas: Population Movement August 2019

IFCR IFCR (2019) CC

In early 2015, the Americas region began to experience a surge in migration flows due in large part to the rise of people emigrating from Venezuela in response to the country’s faltering economy. This swell in migration continued in the years following, as the number of Venezuelans living in Latin... more

Download (800)

View PDF (2525)

WHO Strategic Action Plan for Ebola Outbreak Response

World Health Organization (2014)

Ebola Virus Disease Outbreak Response Plan in West Africa July to December 2014. Annex 1

Download (337)

View PDF (497)

Ebola Synthesis Reference Document

Powell, Steve and others International Federation of Red Cross and Red Crescent Societies (IFRC) (2017) C1

Download (147)

View PDF (177)

The 2018 optimal formulary and limited-use list for pediatric ARVs

World Health Organization; Unicef; USAID; et al. (2018) C_WHO

Policy Brief

Download (157)

View PDF (232)

COVID-19 in the Americas: Listening to the most vulnerable - Community perceptions from migrants, refugees, host communities and indigenous populations

The International Federation of Red Cross and Red Crescent Societies IFRC (2022) CC

This research report offers community perceptions of COVID-19 from migrants, refugees, host communities and indigenous populations in nine countries in the Americas: Argentina, Brazil, Bolivia, Colombia, Guatemala, Nicaragua, Jamaica, Panama and Trinidad and Tobago. It reveals the myriad impacts ... more

Download (340)

View PDF (634)

Yemen: The World’s Worst Humanitarian Crisis Enters Another Year

Andrea Carboni Armed Conflict Location and Events Dataset (2018) C1

Four years after the Houthi takeover of the capital Sana’a and the beginning of the Saudi-led military intervention, there is little to suggest that Yemen will find peace in the near future. As of January 2018, the conflict has killed tens of thousands of people and displaced millions, causing wid... more

Download (508)

View PDF (896)

Running the Ebola Response: The Triple Helix of Information, Logistics and Coordination

The Disaster Resilience Lab (2014)

Preliminary Key Findings from Interviews in Accra on the Ebola Response

Download (349)

View PDF (364)

Youth-centred digital health digital health interventions

World Health Organization WHO (2020) C_WHO

A framework for planning, developing and implementing solutions with and for young people. The guidance presented in this document is intended for digital health intervention designers, developers, implementers, researchers and funders. Newcomers to digital health can use it as a start-to-finish pr... more

Download (373)

View PDF (369)

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

World Health Organization WHO (2023) CC

Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected. Infection prevention and control (IP... more

Download (625)

View PDF (1274)

Zika Strategic Response Plan Quarterly update, October 2016

World Health Organization WHO (2016) C_WHO

Download (198)

View PDF (242)

Longlist of knowledge gaps in Planetary health

Royal Netherlands Academy of Arts and Sciences (2023) C2

The longlist of knowledge gaps is based on existing research agendas published in 2015 or later and expert input from reviewers of the first draft of the longlist. It only includes knowledge gaps focussing on a better understanding of the relationship between global environmental change and human h... more

Download (431)

View PDF (425)

Клиническое ведение тяжелой острой респираторной инфекции: методическое пособие. Версия, адаптированная для борьбы с COVID-19
recommended

World Health Organization WHO (2020) C_WHO

Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation

External Link

TACKLING ANTIMICROBIAL RESISTANCE (AMR) TOGETHER Working Paper 5.0: Enhancing the focus on gender and equity

World Health Organization WHO (2018) C_WHO

This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e... more

Download (162)

View PDF (201)

Solidarity in response to the COVID-19 pandemic

Rahman-Shepherd, A.; C. Clift; E. Ross; et al. The Chatham House (2021) CC

Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec... more

Download (356)

View PDF (468)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (765)

View PDF (1167)

Handbook for Emergencies

UNHCR (2007) C2

Section One summarizes UNHCR’s mandate of international protecdtion and the aim and principles of emergency response; Section Two deals with emergency management; Section Three covers the vital sectors and problem areas in refugee emergencies, including health, food, sanitation and water, a... more

Amnesty International Report 2021/22: The state of the world's human rights recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023 recommended

Клиническое ведение тяжелой острой респираторной инфекции: методическое пособие. Версия, адаптированная для борьбы с COVID-19 recommended

Amnesty International Report 2021/22: The state of the world's human rights
recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

Клиническое ведение тяжелой острой респираторной инфекции: методическое пособие. Версия, адаптированная для борьбы с COVID-19
recommended